VIAF

Virtual International Authority File

Search

Leader     00000nz a2200037n 45 0
001     WKP|Q87399775  (VIAF cluster)  (Authority/Source Record)
003     WKP
005     20241221010741.0
008     241221nneanz||abbn n and d
035 ‎‡a  (WKP)Q87399775‏
024 ‎‡a  0000-0003-4622-618X‏ ‎‡2  orcid‏
035 ‎‡a  (OCoLC)Q87399775‏
100 0 ‎‡a  Ivan O Rosas‏ ‎‡c  researcher‏ ‎‡9  en‏
375 ‎‡a  1‏ ‎‡2  iso5218‏
400 0 ‎‡a  Ivan O Rosas‏ ‎‡c  wetenschapper‏ ‎‡9  nl‏
670 ‎‡a  Author's A comparison of visual and quantitative methods to identify interstitial lung abnormalities‏
670 ‎‡a  Author's ACTRIIA-Fc rebalances activin/GDF versus BMP signaling in pulmonary hypertension‏
670 ‎‡a  Author's Age-Dependent Susceptibility to Pulmonary Fibrosis Is Associated with NLRP3 Inflammasome Activation‏
670 ‎‡a  Author's Circulating mitochondrial DNA in patients in the ICU as a marker of mortality: derivation and validation‏
670 ‎‡a  Author's Detection of Rheumatoid Arthritis-Interstitial Lung Disease Is Enhanced by Serum Biomarkers.‏
670 ‎‡a  Author's Extensive Citrullination Promotes Immunogenicity of HSP90 through Protein Unfolding and Exposure of Cryptic Epitopes‏
670 ‎‡a  Author's Functional impact of a spectrum of interstitial lung abnormalities in rheumatoid arthritis‏
670 ‎‡a  Author's Genetics and early detection in idiopathic pulmonary fibrosis‏
670 ‎‡a  Author's Interstitial lung abnormalities and reduced exercise capacity‏
670 ‎‡a  Author's Lung volumes and emphysema in smokers with interstitial lung abnormalities‏
670 ‎‡a  Author's Mitochondrial antiviral signalling protein is crucial for the development of pulmonary fibrosis‏
670 ‎‡a  Author's Paraseptal emphysema: Prevalence and distribution on CT and association with interstitial lung abnormalities‏
670 ‎‡a  Author's Short telomeres, telomeropathy, and subclinical extrapulmonary organ damage in patients with interstitial lung disease‏
670 ‎‡a  Author's Single-cell RNA-seq reveals ectopic and aberrant lung-resident cell populations in idiopathic pulmonary fibrosis‏
670 ‎‡a  Author's Statins and pulmonary fibrosis: the potential role of NLRP3 inflammasome activation‏
670 ‎‡a  Author's Subclinical interstitial lung disease: why you should care‏
670 ‎‡a  Author's Targeted inhibition of PI3 kinase/mTOR specifically in fibrotic lung fibroblasts suppresses pulmonary fibrosis in experimental models‏
909 ‎‡a  (orcid) 000000034622618x‏ ‎‡9  1‏
919 ‎‡a  subclinicalinterstitiallungdiseasewhyyoushouldcare‏ ‎‡A  Subclinical interstitial lung disease: why you should care‏ ‎‡9  1‏
919 ‎‡a  statinsandpulmonaryfibrosisthepotentialroleofnlrp3inflammasomeactivation‏ ‎‡A  Statins and pulmonary fibrosis: the potential role of NLRP3 inflammasome activation‏ ‎‡9  1‏
919 ‎‡a  singlecellrnaseqrevealsectopicandaberrantlungresidentcellpopulationsinidiopathicpulmonaryfibrosis‏ ‎‡A  Single-cell RNA-seq reveals ectopic and aberrant lung-resident cell populations in idiopathic pulmonary fibrosis‏ ‎‡9  1‏
919 ‎‡a  shorttelomerestelomeropathyandsubclinicalextrapulmonaryorgandamageinpatientswithinterstitiallungdisease‏ ‎‡A  Short telomeres, telomeropathy, and subclinical extrapulmonary organ damage in patients with interstitial lung disease‏ ‎‡9  1‏
919 ‎‡a  paraseptalemphysemaprevalenceanddistributiononctandassociationwithinterstitiallungabnormalities‏ ‎‡A  Paraseptal emphysema: Prevalence and distribution on CT and association with interstitial lung abnormalities‏ ‎‡9  1‏
919 ‎‡a  mitochondrialantiviralsignallingproteiniscrucialforthedevelopmentofpulmonaryfibrosis‏ ‎‡A  Mitochondrial antiviral signalling protein is crucial for the development of pulmonary fibrosis‏ ‎‡9  1‏
919 ‎‡a  lungvolumesandemphysemainsmokerswithinterstitiallungabnormalities‏ ‎‡A  Lung volumes and emphysema in smokers with interstitial lung abnormalities‏ ‎‡9  1‏
919 ‎‡a  interstitiallungabnormalitiesandreducedexercisecapacity‏ ‎‡A  Interstitial lung abnormalities and reduced exercise capacity‏ ‎‡9  1‏
919 ‎‡a  geneticsandearlydetectioninidiopathicpulmonaryfibrosis‏ ‎‡A  Genetics and early detection in idiopathic pulmonary fibrosis‏ ‎‡9  1‏
919 ‎‡a  functionalimpactofaspectrumofinterstitiallungabnormalitiesinrheumatoidarthritis‏ ‎‡A  Functional impact of a spectrum of interstitial lung abnormalities in rheumatoid arthritis‏ ‎‡9  1‏
919 ‎‡a  extensivecitrullinationpromotesimmunogenicityofhsp90throughproteinunfoldingandexposureofcrypticepitopes‏ ‎‡A  Extensive Citrullination Promotes Immunogenicity of HSP90 through Protein Unfolding and Exposure of Cryptic Epitopes‏ ‎‡9  1‏
919 ‎‡a  detectionofrheumatoidarthritisinterstitiallungdiseaseisenhancedbyserumbiomarkers‏ ‎‡A  Detection of Rheumatoid Arthritis-Interstitial Lung Disease Is Enhanced by Serum Biomarkers.‏ ‎‡9  1‏
919 ‎‡a  circulatingmitochondrialdnainpatientsintheicuasamarkerofmortalityderivationandvalidation‏ ‎‡A  Circulating mitochondrial DNA in patients in the ICU as a marker of mortality: derivation and validation‏ ‎‡9  1‏
919 ‎‡a  agedependentsusceptibilitytopulmonaryfibrosisisassociatedwithnlrp3inflammasomeactivation‏ ‎‡A  Age-Dependent Susceptibility to Pulmonary Fibrosis Is Associated with NLRP3 Inflammasome Activation‏ ‎‡9  1‏
919 ‎‡a  targetedinhibitionofpi3kinasemtorspecificallyinfibroticlungfibroblastssuppressespulmonaryfibrosisinexperimentalmodels‏ ‎‡A  Targeted inhibition of PI3 kinase/mTOR specifically in fibrotic lung fibroblasts suppresses pulmonary fibrosis in experimental models‏ ‎‡9  1‏
919 ‎‡a  actriiafcrebalancesactivingdfversusbmpsignalinginpulmonaryhypertension‏ ‎‡A  ACTRIIA-Fc rebalances activin/GDF versus BMP signaling in pulmonary hypertension‏ ‎‡9  1‏
919 ‎‡a  comparisonofvisualandquantitativemethodstoidentifyinterstitiallungabnormalities‏ ‎‡A  A comparison of visual and quantitative methods to identify interstitial lung abnormalities‏ ‎‡9  1‏
946 ‎‡a  b‏ ‎‡9  1‏
996 ‎‡2  BNE|XX1515046
996 ‎‡2  SUDOC|24369654X
996 ‎‡2  DNB|1205076565
996 ‎‡2  ISNI|0000000044902269
996 ‎‡2  ARBABN|000049021
996 ‎‡2  DNB|1289101450
996 ‎‡2  RERO|A003759525
996 ‎‡2  DNB|118602586
996 ‎‡2  J9U|987007267236205171
996 ‎‡2  BNC|981058609780406706
996 ‎‡2  NTA|130555320
996 ‎‡2  NII|DA09255113
996 ‎‡2  LC|n 85815411
996 ‎‡2  N6I|vtls001225143
996 ‎‡2  NTA|06970192X
996 ‎‡2  SUDOC|250379945
996 ‎‡2  BNCHL|10000000000000000013408
996 ‎‡2  LC|no2011133646
996 ‎‡2  ISNI|0000000028288203
996 ‎‡2  NYNYRILM|86050
996 ‎‡2  ISNI|0000000019469627
996 ‎‡2  LC|no2017003352
996 ‎‡2  BNE|XX4672165
996 ‎‡2  LC|n 91015878
996 ‎‡2  SUDOC|168998408
996 ‎‡2  LC|no2020069098
996 ‎‡2  LC|n 2021055285
996 ‎‡2  ARBABN|000022751
996 ‎‡2  BNF|12133790
996 ‎‡2  RERO|A018338471
996 ‎‡2  LC|n 50082051
996 ‎‡2  LC|no2006116693
996 ‎‡2  ISNI|0000000392787164
996 ‎‡2  SUDOC|029787475
996 ‎‡2  DNB|1051353319
996 ‎‡2  BIBSYS|8070311
996 ‎‡2  BNCHL|10000000000000000871493
996 ‎‡2  SZ|118602586
996 ‎‡2  ISNI|0000000121334956
996 ‎‡2  ISNI|0000000029621565
996 ‎‡2  DNB|1060561999
996 ‎‡2  BNC|981058609796306706
996 ‎‡2  LC|no2014084253
996 ‎‡2  LC|n 2016002017
996 ‎‡2  DNB|1204569436
996 ‎‡2  BIBSYS|90155419
996 ‎‡2  PTBNP|1843553
996 ‎‡2  DNB|1323164820
996 ‎‡2  LC|n 2012073801
996 ‎‡2  PLWABN|9810699245205606
996 ‎‡2  LC|n 00099329
996 ‎‡2  CAOONL|ncf11221248
996 ‎‡2  CAOONL|ncf11888788
996 ‎‡2  ISNI|0000000456976512
996 ‎‡2  BLBNB|000337028
996 ‎‡2  BAV|495_198384
996 ‎‡2  BNC|981058602352306706
996 ‎‡2  BNE|XX1139839
996 ‎‡2  NLA|000035690395
996 ‎‡2  BNC|981058516792306706
996 ‎‡2  SUDOC|276597168
997 ‎‡a  0 0 lived 0 0‏ ‎‡9  1‏